Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

InMed Pharmaceuticals Inc

INM
Current price
0.24 USD +0.015 USD (+6.91%)
Last closed 0.23 USD
ISIN CA4576375022
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 478 561 USD
Yield for 12 month -43.97 %
1Y
3Y
5Y
10Y
15Y
INM
21.11.2021 - 28.11.2021

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, which is a small molecule compound acting as a selective dual CB1 /CB2 agonist; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. Address: 885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

20 USD

P/E ratio

Dividend Yield

Current Year

+8 094 547 000 USD

Last Year

+4 135 561 USD

Current Quarter

+8 090 444 647 USD

Last Quarter

+1 172 601 USD

Current Year

+1 100 913 000 USD

Last Year

+1 403 036 USD

Current Quarter

+1 100 428 540 USD

Last Quarter

+139 076 USD

Key Figures INM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 914 830 USD
Operating Margin TTM -156.58 %
PE Ratio
Return On Assets TTM -39.22 %
PEG Ratio
Return On Equity TTM -72.09 %
Wall Street Target Price 20 USD
Revenue TTM 4 597 730 USD
Book Value 1.03 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -44.5 %
Dividend Yield
Gross Profit TTM 1 403 036 USD
Earnings per share -1.01 USD
Diluted Eps TTM -1.01 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -166.94 %

Dividend Analytics INM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 07.09.2022
Dividend Date 06.07.2020

Stock Valuation INM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.4657
Price Sales TTM 0.7566
Enterprise Value EBITDA 0.9967
Price Book MRQ 0.3779

Financials INM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INM

For 52 weeks

0.12 USD 0.52 USD
50 Day MA 0.27 USD
Shares Short Prior Month 93 164
200 Day MA 0.29 USD
Short Ratio 0.15
Shares Short 40 007
Short Percent 0.3 %